Under the leadership of CEO Rohan (Ro) Hastie, Metabolon has positioned itself as the global leader in metabolomics, specializing in providing metabolomics solutions for various life science applications, including research, diagnostics, therapeutic development, and precision medicine.
Metabolon's metabolomics platform, complemented by its proprietary metabolomics reference library and expertise in data analysis and translational science, enables customers to address complex questions in life sciences research effectively.
Rohan (Ro) Hastie expressed enthusiasm about the investment, emphasizing Metabolon's role in advancing precision medicine through its innovative metabolomics solutions.
[
add
]
[
|
|
...
]